Darwin Global Management, Ltd
$3.8B Assets Reported
9 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| INSM | INSMED INC | 16,805,184 | $2.6B | 68.3% |
| BLTE | BELITE BIO INC | 3,057,412 | $456M | 12.1% |
| ABVX | ABIVAX SA | 3,468,657 | $352M | 9.3% |
| RVMD | REVOLUTION MEDICINES INC | 2,211,018 | $205M | 5.4% |
| ROIV | ROIVANT SCIENCES LTD | 6,797,300 | $180M | 4.8% |
| DNTH | DIANTHUS THERAPEUTICS INC | 17,357 | $1M | |
| CAPR | CAPRICOR THERAPEUTICS INC | |||
| CDTX | CIDARA THERAPEUTICS INC | |||
| WVE | WAVE LIFE SCIENCES LTD |
Track Darwin Global Management, Ltd's 13F portfolio: $3.8B in reported holdings, 9 positions. Top holdings, AUM, and quarterly changes on SentiSense.